BioNTech SE (BNTX) Tax Provisions (2018 - 2025)

BioNTech SE (BNTX) has 8 years of Tax Provisions data on file, last reported at -$90.3 million in Q4 2025.

• For the quarter ending Q4 2025, Tax Provisions fell 102.71% year-over-year to -$90.3 million; the trailing twelve-month figure through Dec 2025 stood at -$103.4 million (down 803.48% YoY), and the FY2025 full-year result was -$96.4 million, down 827.31% from the prior year.
• Tax Provisions fell to -$90.3 million in Q4 2025, from -$62.4 million in the prior quarter.
• In the past five years, Tax Provisions ranged from a high of $241.5 million in Q2 2023 to a low of -$1.8 billion in Q4 2021.
• A 5-year average of -$485.3 million and a median of -$155.5 million in 2023 frame the typical range for Tax Provisions.
• Across the five-year window, Tax Provisions slumped 920631037.69% in 2021 and jumped 946.17% in 2025, its largest moves.
• Tracing BNTX's Tax Provisions over 5 years: stood at -$1.8 billion in 2021, then jumped by 48.49% to -$912.0 million in 2022, then jumped by 75.78% to -$220.9 million in 2023, then surged by 79.83% to -$44.6 million in 2024, then slumped by 102.71% to -$90.3 million in 2025.
• Business Quant data shows BNTX's Tax Provisions at -$90.3 million in Q4 2025, -$62.4 million in Q3 2025, and $18.2 million in Q2 2025.